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INTRODUCrION
IN 1950 Waldenstrom first drew attention to the occurrence of a form of chronic
liver disease in young people, predominantly adolescent girls, in whom there was
moderate jaundice, enlargement of the liver and spleen, acne, amenorrhoea and
hyperglobulinaemia. The occurrence of fever, arthralgia and Cushingoid
features was noted (Kunkel et al 1951, Beam et al 1956), the LE cell phenomenon
was reported (Joske and King 1955) and the condition was called lupoid hepatitis
(Mackay et al 1956). Over the years it has been given many other names including
liver disease in young women l(Beam et al 1956) with hypergammaglobulinaemia
(Jones and Castleman 1962), active juvenile cirrhosis (Read et al 1963), plasma cell
hepatitis (Page et al 1964), autoclastic lupoid hepatitis (Naish 1960) and auto-
immune hepatitis ;(Mackay et al 1965), each emphasising particular pathological or
clinical features. In recent years the term active chronic hepatitis has gained general
acceptance because it embodies two of the essential pathological and clinical
features of the disorder, namely its chronic and therefore usually progressive nature
and the activity of the process typically manifested by the recurring episodes of
hepatitis which punctuate its course. Lately Sherlock (1975), with a view to further
refining the nomenclature of chronic hepatitis, has proposed that the classical type
be called active chronic "lupoid" (HBAg negative) hepatitis.
Although the main pathological process occurs in the liver the striking
immunological disturbance and the wide spectrum of symptoms indicate
that it is a systemic disease. Discussion continues on ithe role of altered
immune responses in the pathogenesis of active chronic hepatitis, and the absence
of a marker for the virus of hepatitis A has been a great obstacle to progress. It
seems probable that liver cell damage caused by a variety of agents including drugs
(Reynolds et al 1971, Hoyumpa and Connell 1973, Russell et al 1973) may, in
susceptible individuals, initiate self-perpetuating hepatitis. The growing belief that
genetic factors may predetermine the susceptibility of the host has been strengthened
by the discovery of a high prevalence of antibodies and of abnormal levels of
immunoglobulins in relatives of patients with active chronic hepatitis, and also by a
significant associated incidence of diseases which are normally regarded as having
an immunological basis (Galbraith et al 1974). The high frequency of histocom-
patibility antigens HL-A 1 and HL-A 8 in patients with HBAg negative active
chronic hepatitis is in sharp contrast with the normal frequency of H1L-A 1 and the
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(Galbraith et al 1974). The experimental production of a chronic aggressive hepa-
titis-like lesion in rabbits by prolonged immunisation with human liver-specific
lipoprotein, and the con-firmaton of the presence of hypersensitivity to human liver-
specific lipoprotein in patients with active chronic hepatitis, have underlined the
probable role of disturbances of cellular immunity in the pathogenesis of active
chronic hepatitis. It seems likely that the non-organ-specific auto-antibodies (anti-
nuclear antibody, smooth muscle antibody and mitochondrial antibody) merely
reflect an abnormal immune system, perhaps genetically determined, and stimulated
to auto-antibody production by viral or drug-induced hepatic damage (Smith et al
1975).
DEFINITION
Active chronic hepatitis is an inflammatory disease of the liver which has a
variable and usually unremitting course characterised by the clinical, laboratory and
histological changes of both active and chronic hepatitis. While a presumptive
diagnosis can often be made from the clinical and laboratory data, a definitive
diagnosis requires histological examination of the liver, for only in this way may it
be possible to differentiate active chronic hepatitis from prolonged virus hepatitis,
chronic persistent hepatitis, primary biliary cirrhosis and certain other disorders.
PATIENTS
The 40 patients who form the basis of this investigation were seen personally at
the Royal Victoria Hospital during the 15-year period 1961-1975 and include all
those in whom a firm diagnosis of HBAg negative active chronic hepatitis was made.
Many of them continue to attend the Liver Clinic regularly and have been followed
up for between four months and 13 years, the mean follow-up being five and a half
years.
In general the diagnosis was based on the history and clinical findings, the
biochemical, haematological and serological data and the information provided by
histological examination of the liver. Those patients in whom liver biopsy was
initially omitted, contraindicated or refused (4) or was technically unsuccessful (2)
were accepted on the strength of the other evidence available.
A diagnosis of active chronic hepatitis is entertained when there is clinical or
biochemical evidence of inflammatory liver disease for a period of at least six
months. It must be distinguished from prolonged virus hepatitis and chronic per-
sistent hepatitis both of which are likely to heal completely without treatment.
Active chronic hepatitis associated with HBAg and that due to the administration
of drugs such as oxyphenisatin, methyldopa, isonicotinic acid and, rarely, chlor-
promazine. Wilson's Disease and alpha, antitrypsin deficiency also have to be kept
in mind.
85PATHOLOGY
Liver histology was available in 35 patients, in 27 following percutaneous needle
liver biopsy and in a further 7 following wedge biopsy obtained at laparotomy. The
only histological material available in one case was obtained at autopsy more than
four years after the onset of the illness.
In 29 cases the appearances were those of active chronic hepatitis in various
stages of activity and progression (De Groote et al 1968, Scheuer 1968). In 13
there was perilobular liver cell degeneration and necrosis with collapse of the
reticulin framework particularly in the neighbourhood of the portal triads and
resulting in disruption of the limiting plates. Piecemeal necrosis was noted and the
severity of the parenchymal lesion varied considerably from lobule to lobule. A
striking inflammatory cell infiltrate, consisting mainly of lymphocytes with plasma
cells and some polymorphs and eosinophils, was usually concentrated in and
around the enlarged portal tracts. In some cases lymphoid follicles were present
and the inflammatory cells extended into the lobules to a varying degree. Fine
fibrous septa were seen to radiate from the portal tracts and to divide up the liver
lobules into clumps of cells from which early regenerative nodules might be ex-
pected to arise and in 11 cases irregular parenchymal regeneration, intralobular
septa formation and portal tract fibrosis indicated the development of early
cirrhosis.
In five cases the initial appearances of acute, mainly perilobular, hepatitis were
seen to give way in subsequent biopsies to those of early active cirrhosis or late
relatively inactive cirrhosis with little continuing liver cell necrosis or inflammatory
cell infiltration.
There were two patients in whom the initial biopsy was performed either too
early, and merely showed -the changes of acute hepatitis, or too late when post-
necrotic cirrhosis had already developed. In three patients diagnoses of chronic
persistent hepatitis, primary biliary cirrhosis, and ? hepatitis ? cholangitis were
suggested but these patients were also accepted on the basis of the other informa-
tion available. Two patients in whom liver biopsy showed chronic aggressive
hepatitis and early cirrhosis with persistent activity respectively, but with clinical
features of advanced cirrhosis with portal hypertension, were excluded from the
series. Others with clinical and biochemical features in keeping with active chronic
hepatitis but with the histological changes of well developed cirrhosis were also
omitted.
The possible effects of sampling error, progression from one type of liver disorder
to another and changes brought about by moderate dosage immunosuppressive
therapy were observed in two patients. In the first, the initial biopsy showed the
changes of chronic persistent hepatitis whereas 33 months later, in the absence of
treatment, a further biopsy showed active chronic hepatitis with early cirrhosis. In
the second patient, the appearances in the initial biopsy were those of active
chronic hepatitis but after 14 months corticotrophin therapy the second biopsy
showed chronic persistent hepatitis.
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of tissue available for examination and the performance of the biopsy too early or
too late in the course of the illness may greatly detract from the value of the
information which such an examination would be expected to provide. Sherlock
(1975) stresses that serial liver biopsies may be necessary to make a diagnosis of
active chronic hepatitis. Cirrhosis is said to develop early in the course of the
disease and to be already present in one-third of cases when the diagnosis is first
made. Within two years of the onset some degree of cirrhosis is almost inevitable.
Recurring episodes of necrosis with further stromal collapse and fibrosis lead to
increasingly severe macronodular cirrhosis often with shrinkage of the liver.
CLINICAL FEATURES
Age and Sex
The age at onset ranged from 9 to 74 years and in 28 patients (70 per cent)
symptoms commenced between the ages of 30 and 59. This contrasts sharply with
the experience of others (Mistilis and Blackburn 1970, Sherlock 1975) who reported
that half of their patients were in the age groups 10-30 and 10-20 respectively. On
the other hand Soloway et al (1972). found the onset to occur after the age of 40 in
approximately 60 per cent of cases.
It is possible that the differences between these series in the age of onset of
active chronic hepatitis are due in part to differences in the populations from which
the cases are drawn. In view of the fact that in Belfast there are two busy teaching
hospitals devoted to the care of sick children and a large infectious diseases hospital
to which cases of virus hepatitis in children and adults are admitted, it would not
be surprising if a series of patients seen only at the Royal Victoria Hospital con-
tained a relatively small proportion of those in the first two decades of life. As
anticipated there was a considerable female preponderance-28 out of 40 (70 per
cent).
Previous History
In six patients there was a previous history of jaundice highly suggestive of
hepatitis A. The illness occurred between the ages of 5 and 9 in three patients and
at 20, 29 and 42 in the otherthree. The intervals between these episodes of jaundice
and the onset of active chronic hepatitis were 53, 26, 37, 26, 26 and 17 years
respectively.
Family History
A history of jaundice, probably due mainly to hepatitis A, was obtained in near-
relatives of seven patients. Thyroid disease occurred in the immediate families of
10 patients and there were at least six cases of thyrotoxicosis. Diabetes was reported
in five families and where this was insulin-dependant, the patient also had insulin-
dependant diabetes which long preceded the onset of the liver disorder. Major
allergy, anaemia and rheumatic fever were each noted in three families but there
were no instances of ulcerative colitis, rheumatoid arthritis or systemic lupus
erythematosus.
87Onset of the Disease
In 26 patients (65 per cent) the illness began abruptly and was indistinguishable
from acute virus hepatitis. In at least two cases, a boy aged 9 and a girl of 15, the
illness occurred when other children in the same class at school had hepatitis A.
Symptoms such as anorexia, nausea, vomiting, fatigue, malaise, fever, polyarth-
ralgia, right upper abdominal discomfort and the passage of dark urine usually
developed over a period of one to two weeks by which time jaundice was apparent.
In the majority of cases of acute onset symptoms died down after a few weeks.
Jaundice faded, hepatic tenderness and enlargement diminished and the various
laboratory tests showed improvement. In a small minority of such patients (4) all
symptoms and clinical signs of the disorder disappeared completely without any
treatment but there was persistent elevation of serum transaminase and gamma-
globulin levels. After an interval of a few weeks or months (and in one instance
5 years) these patients suffered a hepatitic relapse with recurrence of symptoms
closely resembling those at the onset of the illness. In a good many more patients
(10) recovery began but was incomplete. Appetite and energy were not fully re-
stored, jaundice faded but did not disappear and some liver enlargement remained.
After a few weeks or months there was further deterioration of appetite and energy,
nausea returned, jaundice deepened and hepatic tenderness reappeared. Some
patients experienced several such remissions and relapses in the space of 6-9
months. In yet others (11) the expected recovery failed to occur and the symptoms
of onset persisted in varying degree. Disinclination for food coupled with sickness
and occasionally troublesome diarrhoea led to considerable weight loss and debility.
In some the disorder followed a fluctuating course with variation in the severity of
the symptoms and clinical findings from month to month. After recovery from the
hepatitic illness one patient developed painful swelling of many of the limb joints.
In another an erythematous rash considered to be typical of lupus erythematosus
appeared across the bridge of the nose and there was painful swelling of a number
of the finger joints. LE cells were present in both patients. Although jaundice was
absent, the liver was enlarged and firm and serum transaminase and gammaglobulin
levels were considerably elevated.
In 14 patients (35 per cent)! the onset of the illness was insidious and symptoms
developed over a period of 3 to 14 months. They included polyarthralgia and some-
times swelling of the affected joints, unaccustomed tiredness, an indifferent
appetite, occasional mild nausea, considerable loss of weight, a degree of malaise,
unexplained fever, an unhealthy colour and the eventual appearance of overt
jaundice. One patient however, a girl of 13, has not been noted to be jaundiced
at any time since the onset of the illness. In the four patients in whom polyarthralgia
was the first symptom, the joints usually affected were the fingers, wrists, knees,
ankles and feet and they were often tender and sometimes slightly swollen. A
diagnosis of early rheumatoid arthritis was made in two of them and appropriate
treatment was commenced. Three to 14 months after the onset of polyarthralgia,
symptoms of hepatitis developed acutely in two patients and insidiously in the
other two patients.
88Established Disease
As the months passed and the disease progressed, the syndromes of onset made
way for the gradually emerging clinical picture of active chronic hepatitis. Many
of the early symptoms remained but others were added and examination disclosed
a number of striking new physical signs.
Tables I and II show the principal clinical features in the 40 patients at the time
of diagnosis. Those symptoms occurring most frequently during the course of the
illness were fatigue, rapidly dissipated energy, an indifferent appetite, intermittent
TABLE I
Symptoms in 40 patients with untreated active chrotic hepatitis
Number Percentage
Fatigue .... ...... ..... ...... ..... 31 78
Anorexia .... ..... .... ...... ..... 30 75
Nausea with or without vomiting 26 65
W eightloss ...... ...... ..... ... .... 22 55
Fever .. ...... ...... ...... ..... ..... 18 45
Itching .. ... ..... ..... ..... 14 35
Abdominal discomfort .... ..... ...... 11 28
Polyarthralgia ...... ... .... .... 10 25
Amenorrhoea ..... ... .... .... 7 64*
Epistaxis ..... ...... .... ..... ...... 5 13
Diarrhoea ..... ...... ..... ..... .... 5 13
* There were 11 premenopausal female patients
nausea and in over half the patients weight loss ranging from 4 to 40 lb (1.8-18 k)
with an average of 15 lb (6.8 k). Almost half the patients were feverish and in 10
out of 18 this exceeded 100°F (37.8 C).
In 9 of the 11 patients with abdominal discomfort the illness had commenced as
acute hepatitis and the incidence of hepatic enlargement and tenderness was above
average. Enlargement of the liver was usually present from the onset and when the
disease became established, firm smooth hepatomegaly was the rule with tenderness
in about one-third of cases. In 12 (30 per cent) there was considerable hepatic
enlargement, the lower edge of the right lobe being felt 3-4 finger-breadths (fb)
(6-8 cm) below the right costal margin in full inspiration.
Enlargement of the spleen was felt in 16 patients (40 per cent) at the time of
diagnosis and in 6 the lower pole could be felt 2-4 fb (4-8 cm) below the left costal
margin in full inspiration. In only four of the patients with splenomegaly was there
any suspicion of cirrhosis and none of them had very large spleens. In 11 LE cells
were detected and in six they were found regularly and at times in considerable
numbers.
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Clinical findings in 40 patients with untreated active chronic hepatitis
Number Percentage
Jaundice .... ...... ...... ...... ...... 37 93
Hepatomegaly 33 83
Hepatic tenderness ...... 14 35
Splenomegaly 16 40
Oedema, ascites and encephalopathy ...... 1 2.5
Vascular spiders 19 48
Dilated facial venules ...... ...... ...... 12 30
Palmar erythema 9 23
Acne ...... ...... ...... ...... ...... ...... 3 7.5
Polyarthritis ......
SLE rash 7.5
Pleurisy and pericarditis with effusion ...... 1 2.5
Bilateral pneumonitis and pleurisy
with effusion ...... ...... ............ 1 2.5
Thyroid enlargement 4 10
Jaundice was present in all but three patients at the time of diagnosis. It was
mild in 19 and deep in 11. Itching occurred in one-third of the patients and corre-
lated surprisingly poorly with the intensity of jaundice, being present in only 6
of the 11 most deeply icteric patients. There was no better correlation between
itching and high serum alkaline phosphatase levels, only 6 of the 13 patients
with serum alkaline phosphatase levels above 30 King Armstrong units complaining
of itching.
Vascular spiders were present in almost half the patients but only five patients
(13 per cent) had more than five spiders. However the presence of vascular spiders
and dilated facial venules proved useful in raising the index of suspicion of active
chronic hepatitis in patients with nondescript symptoms and few other physical
signs.
Only one patient developed oedema, ascites and mild hepatic encephalopathy
early in the course of the illness before treatment was commenced. He made a slow
but eventually excellent recovery and remains well 11 years later, never having had
any recurrence of liver cell failure or hepatic encephalopathy. Transient encephalo-
pathy occurred in one other very deeply jaundiced patient as treatment with pred-
nisolone was being introduced. There was no accompanying oedema or ascites and
,he also made a rapid recovery. Years later she developed macronodular cirrhosis
with portal hypertension and variceal bleeding but when last seen 11 years after the
onset of the illness had no fluid retention and was mentally clear.
90Systemic Manifestations and Associated Conditions
"Active chronic hepatitis of lupoid type is not a condition confined to the liver"
(Sherlock 1975). It is a systemic disease in which almost half the sufferers have
associated conditions which are apparently unrelated to the liver. Among these are
polyarthralgia, polyarthritis, a variety of skin lesions including those of lupus
erythematosus, pericarditis, myocarditis, pleurisy, transient pulmonary infiltrations,
fibrosing alveolitis, glomerulonephritis, renal tubular acidosis, the sicca syndrome,
ulcerative colitis and a number of endocrine disorders such as amenorrhoea,
Cushing's syndrome, diabetes and various thyroid abnormalities including Hashi-
moto's thyroiditis. These extra-hepatic syndromes may precede, coincide with or
more frequently follow the onset of clinical liver disease but in general the clinical
picture is dominated by the features of the hepatic lesion.
Amenorrhoea was often present from the beginning of the illness and became
established in 7 of the 11 premenopausal patients but other endocrine disorders
such as obesity, facial mooning, striae livida and hirsutism, traditionally associated
with active chronic hepatitis, did not occur and acne was observed in only three
patients prior to the commencement of corticosteroid or corticotrophin therapy.
This may be partly due to the small number in this series of girls and young women
in whom such symptoms are said to occur most commonly.
Three patients, each with a direct family history, had insulin-dependant diabetes
which long preceded the onset of active chronic hepatitis. Of the five patients with
a thyroid disorder two had non-toxic goitre, one had thyrotoxicosis, another had
thyrotoxicosis treated with radioactive iodine years prior to the onset of active
chronic hepatitis and the fifth patient was found at autopsy to have lymphocytic
thyroiditis.
Polyarthralgia with or without swelling and tenderness of the affected joints was
an important symptom in ten patients (25 per cent) and tended to occur at the onset
or early in the course of the established disease. The joints most frequently affected
were the metacarpo-pharyngeal and proximal interphalangeal joints of the fingers,
the wrists, elbows, ankles and knees. There was no evidence of erosive arthritis nor
were there any of the extraarticular manifestations of rheumatoid disease. The Rose
Waaler D.A.T. was positive in two patients and then only intermittently and in low
titre. In nine of the ten patients however the LE cell phenomenon was positive and
repeatedly so in six patients.
Skin rashes accepted as lupus erythematosus by dermatologists occurred in three
patients. In two patients typical butterfly rashes were seen on the face and there
were two instances of widely distributed lesions on the limbs.
Pericarditis and bilateral pleurisy with effusion occurred two or three months
after the onset of acute hepatitis in one patient in whom LE cells were repeatedly
demonstrated. A complete clinical recovery occurred over a period of six months
without treatment but the electrocardiogram did not return to normal for almost
one year and the serum transaminase and gammaglobulin levels remained elevated.
In another patient pneumonitis and bilateral pleurisy with effusion occurred four
91months after the onset of the illness which was characterised by polyarthritis.
LE cells were also demonstrated repeatedly in this patient whose condition did
not begin to improve until prednisolone was given in high dosage. During life this
patient did not exhibit any signs of renal or thyroid disease but was found at
autopsy to have electron microscopic appearances diagnostic of the renal lesion of
lupus erythematosus and the histological changes of lymphocytic thyroiditis sugges-
tive of Hashimoto's disease.
Diarrhoea was a prominent symptom from the onset of the illness in five patients,
only disappearing in three patients when corticosteroid or corticotrophin therapy
was commenced and continuing in the other two. The changes of ulcerative colitis
have not been demonstrated in any of these patients though this condition has been
reported to occur in up to 11 per cent of cases of active chronic hepatitis (Mistilis
1969). Instances of the sicca syndrome, renal tubular acidosis and interstitial
pulmonary fibrosis were not observed in this series.
Course of the Disease
From time to time the tempo of the illness quickened with the occurrence of
episodes of active hepatitis or polyarthritis. While these were most frequent early
in the course of the disease, patients remained liable to such reactivation many years
after the onset. Of the 40 patients in this series, 30 suffered a total of more than
56 relapses while not receiving treatment, and 47 of these episodes seemed to be
purely hepatic in type. Six relapses, all occurring in the same patient, were charac-
terised by painful and swollen joints, a butterfly rash on the face and splenomegaly,
but with no clinical or biochemical evidence of reactivation of the liver lesion save
in one episode. In another patient the relapse consisted solely of polyarthritis and
there was no evidence of accompanying liver involvement. In the remaining two
relapses, patients had painful swollen joints and also symptoms and signs of active
hepatitis.
In some of the relapses, symptoms came on quickly while in others they de-
veloped insidiously over a period of several weeks. They often closely resembled
those which originally ushered in the illness. They varied in severity from little
more than tiredness, malaise and an indifferent appetite with moderate elevation
of serum transaminase and gammaglobulin levels to grave illness with deep jaun-
dice, peripheral oedema, ascites and hepatic encephalopathy. Three of the relapses
were symptomless and were discovered only as a result of routine biochemical
screening. Some occurred spontaneously while others were precipitated by inter-
current infection especially influenza and other virus infections. Similar relapses
have been seen in patients receiving corticosteroid or corticotrophin therapy and
have often followed injudicious reduction of dosage or premature withdrawal of
treatment.
Minor relapses sometimes resolved spontaneously but the initiation of effective
treatment usually brought about a quick remission so that even those with evidence
of serious liver-cell failure made a remarkable recovery over a period of a few
weeks or months.
92Often between such episodes appetite and energy returned, jaundice vanished and
hepatic tenderness and enlargement disappeared. In some, evidence of a persisting
hepatic disorder was to be found only by repeating the relevant biochemical tests
though it is well recognised that the histological abnormalities remain. The disease
is said ultimately to become inactive in about 40 per cent of cases by which time
established cirrhosis is present. At the other extreme however the course of the
disease is progressively downhill and as cirrhosis advances the liver shrinks, portal
hypertension develops and the spleen enlarges. Episodes of variceal bleeding occur
and there is increasingly severe liver cell failure and hepatic encephalopathy.
Active chronic hepatitis is a disease in which there is considerable morbidity.
During the early stages, this is due to the fluctuating course with episodes of active
hepatitis and to persisting debility, but during the later stages it results mainly from
the complications of cirrhosis. The mortality rate is also high particularly in the
early stages when activity of the process is greatest and the prognosis is said to be
somewhat better in patients who survive the first two or three years. Death is usually
due to liver cell failure, sometimes precipitated by gastro-intestinal haemorrhage
but septicaemia, associated ulcerative colitis or the complications of prolonged
corticosteroid or corticotrophin therapy may also contribute.
HAEMATOLOGICAL, BoICHEMICAL AND SEROLOGICAL FEATURES
The serum haematological and biochemical findings are shown in Table III. For
each investigation the immediate pre-treatment result or the mean of several results
for each patient was used to calculate the median and range for the whole group.
TABLE III
Haematological and biochemical findings in patients with untreated
active chronic hepatitis
Number Mediant Range
ESR (mm/I hour Westergren) 38 39 4 - 125
RCC(106 per microlitre) 22 4.2 2.7 - 5.0
WCC (per microlitre) 36 5,300 2,800- 11,300
Serum bilirubin (mg/decilitre) 40 4.4 0.6 - 28
Serum alkaline phosphatase 40 27 10 - 150
(King Armstrong units)
SGOT (Karmen units) 39 350 90 -3,000
SGPT (Karmen units) 39 320 60- 1,720
Serum pseudocholinesterase 34 36 5 - 119
(Michel units)
Prothrombin concentration (%/,) 24 45 17.5 - 93
Serum albumin(g/decilitre) 36 3.5 2.3 - 4.6
Serum y-globulin (g/decilitre) 36 2.7 1.1 - 6.0
Serum IgG (mg/decilitre) 20 2,000 1,000(- >3,000
Serum IgM (mg/decilitre) 20 270 86 - >400
93The ESR varied widely, values of more than 100 mm being recorded in 6
patients and less than 20 in 9 patients. A platelet count of less than 150,000/ml was
obtained in almost one-third of patients, the total white cell count was less than
4,000/ml in almost one-quarter of patients and mild anaemia was not uncommon.
Serum bilirubin was less than 1 mg in 3 patients, 1-5 mg in 19 patients, 5-10 mg
in 7 patients and more than 10 mg in 11 patients with figures exceeding 20 mg in
4 patients. Serum alkaline phosphatase was usually increased above 15 King Arm-
strong units and levels of over 30 King Armstrong units were recorded in 13
patients. Serum transaminases were increased to at least twice the upper limit of
normal in every case and often reached levels occurring in acute virus hepatitis,
being more than 1,000 Karmen units in 12 patients (30 per cent).
Impairment of liver cell synthesizing function was reflected in depressed serum
pseudo-cholinesterase, prothrombin and albumin concentrations. Pseudo-cholines-
terase was reduced below 53 Michel units in 28 patients (82 per cent) and below
20 Michel units in three patients. Hypoprothrombinaemia was frequent and the
prothrombin concentration was less than 30 per cent (Quick one-stage method) in
five patients (20 per cent). Serum albumin levels of less than 3 g/dl were recorded
in eight patients (22 per cent), but marked hypoalbuminaemia was unusual until
the later stages of the disease.
Serum gammaglobulin levels were higher than 1.5 g/dl in 30 patients (83 per cent)
and over 3 g/dl in 15 (42 per cent). The serum Ig G and Ig M levels were increased
above the upper limit of normal in 60 per cent and 80 per cent of patients
respectively.
Serum alpha1 antitrypsin phenotyping was performed in 20 patients and proved
to be Pi M (Pi MiM or Pi M-) in all (Glasgow et al 1976). In Northern Ireland this
is the commonest alpha, antitrypsin phenotype, accounting for more than 80 per
cent of individuals in the normal adult population.
In active chronic hepatitis a wide range of antibodies reacting with various tissues
may be present in the serum (Doniach et al 1966, Smith et al 1975). Persistently
high titres of smooth muscle antibody may be found in two out of three cases and
this is an important aid in diagnosis though the antibody is also found in up to half
of patients with primary biliary cirrhosis and transiently and in low titre in acute
virus hepatitis. Mitochondrial antibody, which has a special relationship to primary
biliary cirrhosis where it is found in 90 to 95 per cent of cases, may also be detected
in about one-quarter of patients with active chronic hepatitis. Antinuclear factor in
a titre of more than 1/20 has been reported in 50 to 60 per cent of cases of active
chronic hepatitis, while the incidence of the LE cell phenomenon varies between
15 per cent (Sherlock 1975) and 34 per cent (Soloway et al 1972) and is said to
depend upon the diligence of the search and the phase of the disease. The results of
the various serological tests are shown in Table IV. The presence of LE cells in
50 per cent of patients, often repeatedly and in large numbers, is noteworthy.
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LE cells and serological reactions in patients with
activechronic hepatitis
Number tested Number positive
LE cells ... ...... .... ..... 40 20 1(50%)
Antinuclearfactor .... ...... 39 21 (54%)
Smooth muscleantibody ..... 38 27 (71%)
Mitochondrial antibody 37 18 (49%)
Rheumatoid factor - Latex 17 7 (41%)
-DAT ..... 17 2 (12%)
HBsAg ... ...... ...... ...... 38 0
DIFFERENTIAL DIAGNOSIS
Active chronic hepatitis may be distinguished from a prolonged attack of virus
hepatitis and from chronic persistent hepatitis by the presence of various clinical
stigmata of chronic liver disease, low serum levels of prothrombin and pseudo-
cholinesterase, hypergammaglobulinaemia, the presence of smooth muscle antibody
and the distinctive histological changes in the liver biopsy. Occasionally patients with
Gilbert's syndrome are suspected of having active chronic hepatitis because of
intermittent or persistent jaundice, fatigue, an indifferent appetite and vague upper
abdominal discomfort. However the absence of abnormal physical signs other than
mild jaundice, and the completely normal liver tests apart from hyperbilirubinaemia
of unconjugated type, obviate the need for liver biopsy.
There are a small number of patients with active chronic hepatitis whose symp-
toms and signs closely resemble those of primary biliary cirrhosis. They tend to be
middle-aged women who complain of troublesome itching and often have persistent
mild jaundice. There is disproportionate elevation of serum alkaline phosphatase
levels and mitochondrial antibodies are usually present in high titre. This "overlap
group" follows a cholestatic course and the response to corticosteroid or corticotro-
phin therapy is unpredictable and often unsatisfactory. The longterm outlook is
appreciably worse in these patients.
Active chronic hepatitis may have to be distinguished from benign recurrent
cholestasis, pericholangitis associated with ulcerative colitis, the various hepatic
granulomas especially sarcoidosis, alcoholic liver disease, fully developed macron-
odular cirrhosis, sclerosing cholangitis and primary hepatoma.
DIscussIoN
The fundamental cause of active chronic hepatitis is still unknown. It may be
due to chronic infection with one of the hepatitis viruses and/or to a disorder of
immunity. There is a good deal of indirect evidence in support of both of these
95possibilities. It is probable that the disease is not due to a single cause but is a con-
tinuing hepatic and systemic response to liver cell injury initially of varied aetiology
in genetically predisposed individuals. In the majority of cases, however, it is likely
that the initial liver damage is caused by virus infection and in the early stages of
the disease the clinical picture may be indistinguishable from acute hepatitis. This
was so in 65 per cent of cases in the present series and in some the illness com-
menced during local epidemics of hepatitis A infection.
This high incidence of illness of acute onset appears to be connected with the
unusually frequent occurrence of a positive LE cell test (50 per cent). Rather more
than half of these patients had sp]enomegaly while the median gammaglobulin level
(2.9 gms.) was higher than in those with a negative LE cell test. This was also the
experience of Soloway et al (1972) who concluded that a positive LE cell test was
associated with disease of greater acuteness and severity and with a poorer prog-
nosis in the absence of effective treatment. However they were unable to identify
any clinical, biochemical, immunochemical or pathological features that character-
ised lupoid hepatitis as a separate entity from LE-negative patients. Nevertheless the
discovery by Davis and Read (1975) in 42 per cent of their patients with active
chronic hepatitis of levels of antibody to double-stranded (native) DNA, usuallyonly
found in systemic lupus erythematosus, again raises the question of the relationship
between these two conditions. They suggest that these antibodies, previously shown
to have a high degree of specificity for systemic lupus erythematosus, may play a
specific role in the immunopathogenesis of active chronic hepatitis.
The occurrence in patients with LE-cell-positive active chronic hepatitis of re-
lapses with features indistinguishable from those seen in systemic lupus erythema-
tosus is of considerable interest. Thus during the long hot summer of 1975 a
54-year-old woman taking 7.5 mg of prednisolone daily developed an acute
erythematous and oedematous rash across the bridge of the nose, on the cheeks,
round the eyes and on the backs of the hands and flitting polyarthralgia with slight
swelling and tenderness of some of the limb joints. There was no clinical or bio-
chemical evidence of reactivation of the hepatic lesion and the condition subsided
uneventfully with appropriate treatment.
In the knowledge that some cases of non-alcoholic cirrhosis of later life have
their beginnings in clinically silent active chronic hepatitis and that with immuno-
suppressive treatment it is often possible to retard the activity and progress of this
disorder, the physician is increasingly conscious of the need to make a firm diag-
nosis as early as possible. In addition to careful clinical, biochemical and haemato-
logical investigation this involves needle liver biopsy. With the widespread use of
biochemical screening procedures examples are coming to light of apparently
healthy persons with abnormal liver tests of the type seen in active chronic hepatitis
(Plotz 1975). Whether or not early treatment of the asymptomatic person with
chronic aggressive hepatitis favourably influences possible longterm pro-
gression to symptomatic cirrhosis and death has yet to be determined. In the great
majority of symptomatic cases of active chronic hepatitis spontaneous remissions
tend to be of limited degree and duration. Even in those patients with few
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the histological appearances may still indicate considerably activity of the under-
lying process. It is therefore probable that other similar cases may pass unrecog-
nised until advanced cirrhosis has developed. By that time the histological appear-
ances of activity may have lessened and if the patient presents with variceal bleed-
ing, ascites or encephalopathy the diagnosis likely to be made is one of cryptogenic
cirrhosis.
In this series as in most others, the great majority of patients with active chronic
hepatitis were mildly jaundiced at the time of diagnosis. Those who are not may
present with unexplained debility, mysterious weight loss, pyrexia of unknown
origin, painless hepatosplenomegaly, amenorrhoea, anaemia or polyarthralgia. The
diagnosis should always be considered in cases of prolonged hepato-cellular jaun-
dice, especially in women, when a careful history for possible medications is nega-
tive and there is a personal or family history of diseases having an immunological
basis.
SUMMARY
Data from 40 consecutive patients seen at the Royal Victoria Hospital fulfilling
the diagnostic criteria of active chronic hepatitis have been analysed in order to
gain insight into the many variations that occur in the clinical syndrome. In general
the clinical and laboratory findings correspond to those recorded in other series
though there were significant differences. The peak age of onset may have been
influenced as much by the availability of large specialised hospitals for the care of
sick children and for the treatment of infectious diseases as by any real variation
in the age incidence. The onset was acute in two-thirds of the patients and insidious
in the remaining one-third which is the reverse of experience elsewhere. The LE cell
phenomenon was positive in 50 per cent of patients and it is notable that in three-
quarters of these the onset of the illness was abrupt and indistinguishable from
acute virus hepatitis. There was a close correlation between the incidence of anti-
nuclear factor and a positive LE cell phenomenon while smooth muscle antibodies
and mitochondrial antibodies were present in 71 per cent and 49 per cent respec-
tively. Considered in conjunction with the personal and family history of thyroid
disease, insulin-dependant diabetes, major allergy and rheumatic fever, and in the
light of evidence now becoming available through HL-A histocompatibility studies,
there are grounds for believing that genetic influences predetermine susceptibility to
active chronic hepatitis. The relationship between this condition and systemic lupus
erythematosus requires further investigation.
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